CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Noveris Health Sciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Noveris Health Sciences Inc
1890-1075 West Georgia Street
Phone: (604) 687-2038p:604 687-2038 VANCOUVER, BC  V6E 3C9  Canada Ticker: CSCS
Business Summary
Noveris Health Sciences Inc., formerly Mydecine Innovations Group Inc., is a biotechnology company developing the next generation of innovative medications and therapies to address mental health disorders such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company focuses on the next generation of psychedelic medicine by creating innovative compounds with unmatched therapeutic potential through its clinical trial efforts with scientific and regulatory expertise.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
6519 Lessors of real property, not elsewhere classified
5912 Drug stores and proprietary stores
8731 Commercial physical and biological research
7372 Prepackaged software
0711 Soil preparation services
0722 Crop harvesting, primarily by machine
0723 Crop preparation services for market, except cotton ginning

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director JasonBirmingham 3/11/2026 2/2/2026
Chief Financial Officer, Corporate Secretary JohnRoss 7/21/2023 9/16/2022
Chief Medical Officer RakeshJetly 8/31/2020 8/31/2020
Director MichaelCallas 3/21/2025 3/21/2025
Director PeterField 3/18/2025 3/18/2025

Business Names
Business Name
0NF
0NFA
CS
5 additional Business Names available in full report.

General Information
Number of Employees: 3 (As of 12/31/2022)
Outstanding Shares: 48,923,002 (As of 3/6/2026)
Stock Exchange: CNQ
Fax Number: (778) 372-1790


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 24, 2026